Accelerated atherosclerosis in haemodialysis patients; Correlation of endothelial function with oxidative DNA damage

Nephrology Dialysis Transplantation

Volumn 27, Issue 3, 2012, Pages 1164-1169

  Kaya, Yuksel ^a   Ari, Elif ^a   Demir, Halit ^b   Soylemez, Nihat ^a   Cebi, Aysegul ^c   Alp, Hakan ^d   Bakan, Ebubekir ^d   Gecit, Ilhan ^b   Asicioglu, Ebru ^e   Beytur, Ali ^f  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

^c GIRESUN UNIVERSITY   (Turkey)

^d ATATÜRK UNIVERSITY   (Turkey)

^e MARMARA UNIVERSITY   (Turkey)

^f INONU UNIVERSITY   (Turkey)

Author keywords

Endothelial dysfunction; Haemodialysis; Oxidative DNA damage

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ADULT; ARTERY BLOOD FLOW; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA DAMAGE; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; LONG TERM CARE; MALE; MOLECULAR PATHOLOGY; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELLS, CULTURED; DEOXYGUANOSINE; DNA DAMAGE; ENDOTHELIUM, VASCULAR; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MALONDIALDEHYDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROGNOSIS; RENAL DIALYSIS; SUPEROXIDE DISMUTASE; SURVIVAL RATE;

EID: 84861164995     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr443     Document Type: Article

References (33)

1. Locatelli F, Marcelli D, Conte F et al. Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto. Nephrol Dial Transplant 2000; 15: 69-80
2. Ma KW, Grene EL, Raij L. Cardiovascular risk factors in chronic renal failure and haemodialysis populations. Am J Kidney Dis 1992; 19: 505-513
3. Fujisawa M, Haramaki R, Miyazaki H et al. Role of lipoprotein (a) and TGF-beta 1 in atherosclerosis of haemodialysis patients. J Am Soc Nephrol 2000; 11: 1889-1895
4. Becker BN, Himmelfarb J, Henrich WL et al. Reassessing the cardiac risk profile in chronic haemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 1997; 8: 475-486
5. Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int 2003; 63: 105-110
6. Menon V, Gul A, Sarnak MJ. Cardiovascular risk factors in chronic kidney disease. Kidney Int 2005; 68: 1413-1418
7. Vita JA, Keaney JF Jr, Raby KE et al. Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome. J Am Coll Cardiol 1998; 31: 980-986
8. Nyyssönen K, Porkkala-Sarataho E, Kaikkonen J et al. Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men. Atherosclerosis 1997; 130: 223-233
9. Holvoet P, Vanhaecke J, Janssens S et al. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998; 98: 1487-1494
10. Demirbag R, Remzi Y?lmaz R, GurM et al. DNA damage and plasma total antioxidant capacity in patients with slow coronary artery flow. Turk Kardiyol Dern Ars 2006; 34: 89-93
11. Witko-Sarsat V, Nguyen-Khoa T, Jungers P et al. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uremia. Nephrol Dial Transplant 1999; 14 (Suppl 1): 76-78
12. Handelman GJ, Walter MF, Adhikarla R et al. Elevated plasma F2- isoprostanes in patients on long-term haemodialysis. Kidney Int 2001; 59: 1960-1966
13. Lucchi L, Iannone A, Bergamini S et al. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during haemodialysis. Artif Organs 2005; 29: 832-837
14. Anderson TJ. Assessment and treatment of endothelial dysfunction. J Am Coll Cardiol 1999; 34: 631-638
15. Van Guldener C, Lambert J, Janssen MJ et al. Endothelium dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant 1997; 12: 14-18
16. Morris ST, McMurray JJ, Rodger RS et al. Impaired endothelium dependent vasodilatation in uraemia. Nephrol Dial Transplant 2000; 15: 1194-2000
17. Kocak H, Gumuslu S, Sahin E et al. Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients. Nephrology (Carlton) 2009; 14: 273-280
18. Sydow K, Münzel T. ADMA and oxidative stress. Atheroscler Suppl 2003; 4: 41-51
19. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572
20. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1116
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
22. Armstrong D. Free radical and antioxidant protocols. Introduction. Methods Mol Biol 1998; 108: 5-8
23. Khoschsorur GA, Winklhofer-Roob BM, Rabl H et al. Evaluation of a sensitive HPLC method for the determination of malondialdehyde and application of the method to different biological materials. Chromatographia 2000; 52: 181-184
24. Paglia DE, Valentine WN. Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169
25. Lin YS, Hung SC, Wei YH et al. GST M1 polymorphism associates with DNA oxidative damage and mortality among haemodialysis patients. J Am Soc Nephrol 2009; 20: 405-415
26. Tarng DC, Huang TP, Wei YH et al. 8-Hydroxy-2'-deoxyguanosine of leucocyte DNA as a marker of oxidative stress in chronic haemodialysis patients. Am J Kidney Dis 2000; 36: 934-944
27. Ames BN. Endogenous oxidative DNA damage, aging, and cancer. Free Radic Res Commun 1989; 7: 121-128
28. Tarng DC, Huang TP, Liu TY et al. Effect of vitamin E-bonded membrane on the 8-hydroxy-2'-deoxyguanosine level in leucocyte DNA of haemodialysis patients. Kidney Int 2000; 58: 790-799
29. Cangemi R, Angelico F, Loffredo L et al. Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid. Free Radic Biol Med 2007; 43: 853-859
30. Engler MM, Engler MB, Malloy MJ et al. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidaemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 2003; 108: 1059-1063
31. Lykkesfeldt J. Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking. Clin Chim Acta 2007; 380: 50-58
32. Oberg BP, McMenamin E, Lucas FL et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004; 65: 1009-1016
33. Stenvinkel P, Ketteler M, Johnson RJ et al. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia- the good, the bad, and the ugly. Kidney Int 2005; 67: 1216-1233